Yorke Justin W. - 05 Aug 2022 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
04 Jan 2023, 16:29:25 UTC
Date Of Original Report
09 Aug 2022
Previous filing
04 Apr 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1,169 +8.5% 14,885 05 Aug 2022 Direct F1, F2
holding PCSA Common Stock 532,563 05 Aug 2022 By Richland Fund, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 Previous filing inadvertently underreported shares beneficially owned by the reporting person.